{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:09:35Z","timestamp":1790161775785,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11655-026-4221-x","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:11:34Z","timestamp":1785222694000},"page":"875-883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Qushi Juanbi Granules Combined with Shenling Baizhu Powder in Rheumatoid Arthritis Patients with Low Disease Activity and Pi Deficiency and Dampness Pattern: A Randomized, Double-Blind, Controlled Trial"],"prefix":"10.1007","volume":"32","author":[{"given":"Yi-hong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-bang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-hang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"4221_CR1","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","volume":"55","author":"S Alivernini","year":"2022","unstructured":"Alivernini S, Firestein GS, McInnes IB. The pathogenesis of rheumatoid arthritis. Immunity 2022;55:2255\u20132270.","journal-title":"Immunity"},{"key":"4221_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/annrheumdis-2019-216243","volume":"79","author":"PH Hsieh","year":"2020","unstructured":"Hsieh PH, Wu O, Geue C, McIntosh E, McInnes IB, Siebert S. Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Ann Rheum Dis 2020;79:771\u2013777.","journal-title":"Ann Rheum Dis"},{"key":"4221_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","volume":"41","author":"K Almutairi","year":"2021","unstructured":"Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int 2021;41:863\u2013877.","journal-title":"Rheumatol Int"},{"key":"4221_CR4","first-page":"26","volume":"37","author":"J Wen","year":"2025","unstructured":"Wen J, Jiang J, Feng M, Shen X, Li X. Trend in burden of rheumatoid arthritis in China from 1990 to 2021. Chin Prev Med J (Chin) 2025;37:26\u201330.","journal-title":"Chin Prev Med J (Chin)"},{"key":"4221_CR5","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","volume":"5","author":"Collaborators GBDRA","year":"2023","unstructured":"Collaborators GBDRA. Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol 2023;5:e594\u2013e610.","journal-title":"Lancet Rheumatol"},{"key":"4221_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/ard.2011.149765","volume":"70","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70:404\u2013413.","journal-title":"Ann Rheum Dis"},{"key":"4221_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016;75:3\u201315.","journal-title":"Ann Rheum Dis"},{"key":"4221_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13075-025-03491-1","volume":"27","author":"M Nomura","year":"2025","unstructured":"Nomura M, Sugihara T, Baba H, Hosoya T, Kamiya M, Ishizaki T, et al. Long-term outcome of a treat-to-target strategy in late-onset rheumatoid arthritis with chronic lung disease: 5-year results of a prospective observational study. Arthritis Res Ther 2025;27:22.","journal-title":"Arthritis Res Ther"},{"key":"4221_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.autrev.2019.05.005","volume":"18","author":"A Blum","year":"2019","unstructured":"Blum A, Adawi M. Rheumatoid arthritis (RA) and cardiovascular disease. Autoimmun Rev 2019;18:679\u2013690.","journal-title":"Autoimmun Rev"},{"key":"4221_CR10","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1038\/s41598-025-88323-7","volume":"15","author":"BG Kim","year":"2025","unstructured":"Kim BG, Lee H, Eun Y, Han K, Jung JH, Choi H, et al. Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study. Sci Rep 2025;15:4885.","journal-title":"Sci Rep"},{"key":"4221_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/25785826.2025.2460267","volume":"48","author":"H Hanaoka","year":"2025","unstructured":"Hanaoka H, Aoki T, Kosaka T, Yoshinaga S, Shibata A, Sakai R, et al. Chronic kidney disease and inflammatory cytokines in rheumatoid arthritis: a potential pathogenic link. Immunol Med 2025;48:161\u2013170.","journal-title":"Immunol Med"},{"key":"4221_CR12","doi-asserted-by":"publisher","first-page":"e004744","DOI":"10.1136\/rmdopen-2024-004744","volume":"11","author":"V Bala","year":"2025","unstructured":"Bala V, Hafstrom I, Svensson B, Ajeganova S. Persistently different patterns of patient\u2019s global assessment of health in rheumatoid arthritis are associated with pain and impaired function more than with inflammation: an inception cohort study over 15 years. RMD Open 2025;11:e004744.","journal-title":"RMD Open"},{"key":"4221_CR13","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet 2017;389:2338\u20132348.","journal-title":"Lancet"},{"key":"4221_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/annrheumdis-2015-207526","volume":"75","author":"MA Stoffer","year":"2016","unstructured":"Stoffer MA, Schoels MM, Smolen JS, Aletaha D, Breedveld FC, Burmester G, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Ann Rheum Dis 2016;75:16\u201322.","journal-title":"Ann Rheum Dis"},{"key":"4221_CR15","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/art.39626","volume":"68","author":"M Ghiti Moghadam","year":"2016","unstructured":"Ghiti Moghadam M, Vonkeman HE, Ten Klooster PM, Tekstra J, van Schaardenburg D, Starmans-Kool M, et al. Stopping tumor necrosis factor inhibitor treatment in patients with established rheumatoid arthritis in remission or with stable low disease activity: a pragmatic multicenter, open-label randomized controlled trial. Arthritis Rheumatol 2016;68:1810\u20131817.","journal-title":"Arthritis Rheumatol"},{"key":"4221_CR16","doi-asserted-by":"publisher","first-page":"154816","DOI":"10.1016\/j.phymed.2023.154816","volume":"115","author":"Z Yang","year":"2023","unstructured":"Yang Z, Liang Q, Liang H, Chen W, Li C, Xiao Y, et al. Single-cell RNA transcriptomic and plasma lipidomic reveal the potential mechanisms of a methotrexate-based therapy against rheumatoid arthritis. Phytomedicine 2023;115:154816.","journal-title":"Phytomedicine"},{"key":"4221_CR17","doi-asserted-by":"crossref","unstructured":"Cameron M, Gagnier JJ, Chrubasik S. Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst Rev 2011:CD002948.","DOI":"10.1002\/14651858.CD002948.pub2"},{"key":"4221_CR18","doi-asserted-by":"publisher","first-page":"686360","DOI":"10.3389\/fphar.2021.686360","volume":"12","author":"X Tang","year":"2021","unstructured":"Tang X, Liu Z, Yang Z, Xu S, Wang M, Chen X, et al. The effect of Chinese medicine compound in the treatment of rheumatoid arthritis on the level of rheumatoid factor and anti-cyclic citrullinated peptide antibodies: a systematic review and meta-analysis. Front Pharmacol 2021;12:686360.","journal-title":"Front Pharmacol"},{"key":"4221_CR19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3389\/fphar.2018.00914","volume":"9","author":"X Cai","year":"2018","unstructured":"Cai X, Chen XM, Xia X, Bao K, Wang RR, Peng JH, et al. The bone-protecting efficiency of Chinese medicines compared with Western medicines in rheumatoid arthritis: a systematic review and meta-analysis of comparative studies. Front Pharmacol 2018;9:914.","journal-title":"Front Pharmacol"},{"key":"4221_CR20","doi-asserted-by":"publisher","first-page":"1135803","DOI":"10.3389\/fphar.2023.1135803","volume":"14","author":"L Mei","year":"2023","unstructured":"Mei L, Gao K, He X, Jakobsson PJ, Huang R. Editorial: disease-modifying antirheumatic drugs: approaches and lessons learned from traditional medicine. Front Pharmacol 2023;14:1135803.","journal-title":"Front Pharmacol"},{"key":"4221_CR21","first-page":"2168","volume":"37","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Yan JY, Huang RY. Analysis of traditional Chinese medical syndrome patterns and herbal prescription regularity of rheumatoid arthritis patients in related reports prescription regularity of rheumatoid arthritis patients in related reports. Chin Arch Tradit Chin Med (Chin) 2019;37:2168\u20132177.","journal-title":"Chin Arch Tradit Chin Med (Chin)"},{"key":"4221_CR22","first-page":"24","volume":"7","author":"Y Wen","year":"2026","unstructured":"Wen Y, Wang T, Liu Z, Liang WD, Peng JH, Yao XM, et al. Clinical research on three traditional Chinese medicine formulas for the prevention and treatment of rheumatoid arthritis. Clin Tradit Med Pharmacol (Chin) 2026;7:24\u201333.","journal-title":"Clin Tradit Med Pharmacol (Chin)"},{"key":"4221_CR23","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 2012;64:640\u2013647.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4221_CR24","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569\u20132581.","journal-title":"Arthritis Rheum"},{"key":"4221_CR25","volume-title":"Diagnostic criteria of Spleen deficiency and dampness pattern in rheumatoid arthritis: T\/CACM 1347-2021","author":"Chinese Association of Traditional Chinese Medicine","year":"2021","unstructured":"Chinese Association of Traditional Chinese Medicine. Diagnostic criteria of Spleen deficiency and dampness pattern in rheumatoid arthritis: T\/CACM 1347-2021. Beijing: Chinese Association of Traditional Chinese Medicine;2021."},{"key":"4221_CR26","doi-asserted-by":"publisher","first-page":"1362161","DOI":"10.3389\/fphar.2024.1362161","volume":"15","author":"B Tang","year":"2024","unstructured":"Tang B, Zheng X, Luo Q, Li X, Yang Y, Bi Y, et al. Network pharmacology and gut microbiota insights: unraveling Shenling Baizhu Powder\u2019s role in psoriasis treatment. Front Pharmacol 2024;15:1362161.","journal-title":"Front Pharmacol"},{"key":"4221_CR27","volume-title":"Sample size calculations in clinical research","author":"SC Chow","year":"2008","unstructured":"Chow SC, Shao J, Wang H, eds. Sample size calculations in clinical research. 2nd ed. CRC Press;2008.","edition":"2nd ed."},{"key":"4221_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019 t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44\u201348.","journal-title":"Arthritis Rheum"},{"key":"4221_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-1-20","volume":"1","author":"B Bruce","year":"2003","unstructured":"Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003;1:20.","journal-title":"Health Qual Life Outcomes"},{"key":"4221_CR30","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/acr.20621","volume":"63","author":"JK Anderson","year":"2011","unstructured":"Anderson JK, Zimmerman L, Caplan L, Michaud K. Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score- II (PAS II), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score with ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res (Hoboken) 2011;63:S14\u2013S36.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4221_CR31","doi-asserted-by":"publisher","first-page":"114133","DOI":"10.1016\/j.jpba.2021.114133","volume":"202","author":"J Li","year":"2021","unstructured":"Li J, Li L, Wang Y, Zhao Y, Hu P, Xu Z, et al. Systematic investigation on the anti-rheumatoid arthritis material basis and mechanism of Juan Bi Tang. Part 1: Integrating metabolic profiles and network pharmacology. J Pharm Biomed Anal 2021;202:114133.","journal-title":"J Pharm Biomed Anal"},{"key":"4221_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fphar.2020.00045","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, Jia Q, Chen T, Yin H, Tian X, Lin X, et al. Alleviation of synovial inflammation of Juanbi-Tang on collagen-induced arthritis and TNF-Tg mice model. Front Pharmacol 2020;11:45.","journal-title":"Front Pharmacol"},{"key":"4221_CR33","doi-asserted-by":"publisher","first-page":"106432","DOI":"10.1016\/j.fitote.2025.106432","volume":"182","author":"L Zhang","year":"2025","unstructured":"Zhang L, Wu H, Li X, Zhang X, Li H, Tang H, et al. Screening bioactive compounds from Qianghuo (Notopterygium incisum) volatile oil via COX-2 magnetic ligand fishing. Fitoterapia 2025;182:106432.","journal-title":"Fitoterapia"},{"key":"4221_CR34","doi-asserted-by":"publisher","first-page":"114483","DOI":"10.1016\/j.jep.2021.114483","volume":"280","author":"H Cao","year":"2021","unstructured":"Cao H, Ji W, Liu Q, Li C, Huan Y, Lei L, et al. Morus alba L. (Sangzhi) alkaloids (SZ-A) exert anti-inflammatory effects via regulation of MAPK signaling in macrophages. J Ethnopharmacol 2021;280:114483.","journal-title":"J Ethnopharmacol"},{"key":"4221_CR35","first-page":"179","volume":"25","author":"J Magdalou","year":"2015","unstructured":"Magdalou J, Chen LB, Wang H, Qin J, Wen Y, Li XJ, et al. Angelica sinensis and osteoarthritis: a natural therapeutic link? Biomed Mater Eng 2015;25:179\u2013186.","journal-title":"Biomed Mater Eng"},{"key":"4221_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12906-020-02958-9","volume":"20","author":"J Feng","year":"2020","unstructured":"Feng J, Dai W, Zhang C, Chen H, Chen Z, Chen Y, et al. Shen-Ling-Bai-Zhu-San ameliorates inflammation and lung injury by increasing the gut microbiota in the murine model of Streptococcus pneumonia-induced pneumonia. BMC Complement Med Ther 2020;20:159.","journal-title":"BMC Complement Med Ther"},{"key":"4221_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.nutres.2019.10.001","volume":"71","author":"S Zhang","year":"2019","unstructured":"Zhang S, Lin L, Liu W, Zou B, Cai Y, Liu D, et al. Shen-Ling-Bai-Zhu-San alleviates functional dyspepsia in rats and modulates the composition of the gut microbiota. Nutr Res 2019;71:89\u201399.","journal-title":"Nutr Res"},{"key":"4221_CR38","doi-asserted-by":"publisher","first-page":"110461","DOI":"10.1016\/j.intimp.2023.110461","volume":"121","author":"S Paik","year":"2023","unstructured":"Paik S, Song GY, Jo EK. Ginsenosides for therapeutically targeting inflammation through modulation of oxidative stress. Int Immunopharmacol 2023;121:110461.","journal-title":"Int Immunopharmacol"},{"key":"4221_CR39","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.3390\/molecules28103987","volume":"28","author":"Z Xie","year":"2023","unstructured":"Xie Z, Lin M, He X, Dong Y, Chen Y, Li B, et al. Chemical constitution, pharmacological effects and the underlying mechanism of atractylenolides: a review. Molecules 2023;28:3987.","journal-title":"Molecules"},{"key":"4221_CR40","doi-asserted-by":"publisher","first-page":"110854","DOI":"10.1016\/j.intimp.2023.110854","volume":"124","author":"Y Wu","year":"2023","unstructured":"Wu Y, Ying J, Zhu X, Xu C, Wu L. Pachymic acid suppresses the inflammatory response of chondrocytes and alleviates the progression of osteoarthritis via regulating the Sirtuin 6\/NF-kappaB signal axis. Int Immunopharmacol 2023;124:110854.","journal-title":"Int Immunopharmacol"},{"key":"4221_CR41","doi-asserted-by":"publisher","first-page":"e001220","DOI":"10.1136\/rmdopen-2020-001220","volume":"6","author":"M Verstappen","year":"2020","unstructured":"Verstappen M, van Mulligen E, de Jong PHP, van der Helm-Van Mil AHM. DMARD-free remission as novel treatment target in rheumatoid arthritis: a systematic literature review of achievability and sustainability. RMD Open 2020;6:e001220.","journal-title":"RMD Open"},{"key":"4221_CR42","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00296-014-3010-6","volume":"34","author":"YT He","year":"2014","unstructured":"He YT, Ou AH, Yang XB, Chen W, Fu LY, Lu AP, et al. Traditional Chinese medicine versus Western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study. Rheumatol Int 2014;34:1647\u20131655.","journal-title":"Rheumatol Int"},{"key":"4221_CR43","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s11655-024-3760-2","volume":"30","author":"KX Gao","year":"2024","unstructured":"Gao KX, Yang YH, Liang Q, Mei LY, Liang YB, Wang MJ, et al. Targeting therapeutic windows for rheumatoid arthritis prevention. Chin J Integr Med 2024;30:842\u2013851.","journal-title":"Chin J Integr Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-4221-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:21:43Z","timestamp":1790158903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-4221-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4221"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-4221-x","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"31 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Huang RY is a member of the Young Editorial Board for CJIM. The paper was handled by the other editor and has undergone rigorous peer review process. Author Huang RY was not involved in the journal\u2019s review of, or decisions related to, this manuscript. The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}